1984
DOI: 10.1016/0026-0495(84)90097-0
|View full text |Cite
|
Sign up to set email alerts
|

The effects of aldose reductase inhibition on nerve sorbitol and myoinositol concentrations in diabetic and galactosemic rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
12
0

Year Published

1987
1987
1995
1995

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(13 citation statements)
references
References 20 publications
1
12
0
Order By: Relevance
“…The administration of the AR inhibitor M79,175 (Eisai, Japan) completely prevented these changes from occurring. The effect of AR inhibitor on restoring nerve MI level in galactosemic animal is consistent with the previous findings by Yue et al (1984).…”
Section: Galactitol and MI In Galactosemic Rat Nervesupporting
confidence: 92%
See 1 more Smart Citation
“…The administration of the AR inhibitor M79,175 (Eisai, Japan) completely prevented these changes from occurring. The effect of AR inhibitor on restoring nerve MI level in galactosemic animal is consistent with the previous findings by Yue et al (1984).…”
Section: Galactitol and MI In Galactosemic Rat Nervesupporting
confidence: 92%
“…Another important established fact is that the depletion of MI is related to polyol formation. An inverse relationship has been shown to exist be-tween the gain in polyol and loss in MI in various diabetic and galactosemic tissues (Stewart et al, 1969;Finegold et al, 1983;Yue et al, 1984;MacGregor et al, 1986). Treatment with inhibitors of aldose reductase (AR), the enzyme responsible for polyol synthesis, prevents the MI loss, sorbitol gain, and nerve conduction deficits (Yue et al, 1982;Gillon and Hawthorne, 1983).…”
mentioning
confidence: 99%
“…However, in rat and rabbit sciatic nerve there is conflicting evidence for and against an increased nerve water content [5,6,25,26]. Nor in our own experiments have we been able to observe reduced nerve myo-inositol [2] despite other reports of reductions in myo-inositol in both diabetic and galactosaemic rat nerve [6,20], and the argument that changes in myo-inositol underlie the development of neuropathy and its prevention by inhibitors of aldose reductase [27] in experimental diabetes. It is likely that reduced nerve blood flow and the ensuing, or associated endoneurial hypoxia in both the galactose-fed animal and the streptozotocin-diabetic rat [21][22][23] are amplified in the presence of applied mild pressure, which also impairs nerve blood flow, to the extent that the oxygen-dependent fast axonal transport is inhibited [28,29].…”
Section: Discussionmentioning
confidence: 52%
“…The values quoted above in the nerves of rabbits used for measurements of fast transport rate were typical of the values found throughout; the fact that galactitol and myo-inositol levels were low in the experiments involving nerve compression in the absence of Statii was almost certainly a consequence of the fact that it was necessary to measure galactitol and myo-inositol in the same nerves which had been freeze-dried for measurement of nerve water content and then re-constituted. This also led to a loss of myo-inositol even in nerves from control animals [20].…”
Section: Discussionmentioning
confidence: 98%
“…Recently, the validity of galactose intoxication as a model of diabetic neuropathy has been questioned (18). Galactosemic rats develop deficiencies in slow, retrograde, and turnaround axonal transport (28,54); decreased nerve conduction velocities (55); diminished myo-inositol levels in nerve (18,56); and decreased nerve blood flow (57), as do STZ-D rats. However, diabetic and galactosemic models differ considerably in nerve water content (18), histologic evidence of edema (58), fructose levels (18), and Na + -K + -ATPase activity (42), which is increased in galactosemic nerve.…”
Section: Discussionmentioning
confidence: 99%